KAZANCHYAN ANNA 4
4 · Foamix Pharmaceuticals Ltd. · Filed Mar 3, 2020
Insider Transaction Report
Form 4
KAZANCHYAN ANNA
Director
Transactions
- Award
Ordinary Shares
2020-02-27+21,246→ 58,744 total
Footnotes (2)
- [F1]This security represents restricted share units. Each restricted share unit represents a contingent right to receive one ordinary share of the issuer.
- [F2]The ordinary shares underlying this restricted share unit award vest over a 12 month period, in equal, quarterly installments, ending February 27, 2021.